|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) VA Connecticut Healthcare System |
|---|---|
| Information provided by: | National Institute on Drug Abuse (NIDA) |
| ClinicalTrials.gov Identifier: | NCT00000282 |
Purpose
The purpose of this study is to evaluate the treatment of pemoline for cocaine abuse.
| Condition | Intervention | Phase |
|---|---|---|
|
Cocaine-Related Disorders |
Drug: Pemoline |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment |
| Official Title: | Pemoline for Cocaine Abuse |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Please contact site for information.
Contacts and Locations| United States, Connecticut | |
| VA Connecticut Healthcare System | |
| New Haven, Connecticut, United States, 06519 | |
| Principal Investigator: | Thomas R Kosten, M.D. | VA Connecticut Healthcare System |
More Information
| Study ID Numbers: | NIDA-09250-7, P50-09250-7 |
| Study First Received: | September 20, 1999 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00000282 History of Changes |
| Health Authority: | United States: Federal Government |
|
Cocaine-Related Disorders Pemoline Mental Disorders Substance-Related Disorders |
Disorders of Environmental Origin Central Nervous System Stimulants Cocaine |
|
Cocaine-Related Disorders Pemoline Mental Disorders Therapeutic Uses Physiological Effects of Drugs |
Substance-Related Disorders Disorders of Environmental Origin Central Nervous System Stimulants Central Nervous System Agents Pharmacologic Actions |